We are looking to appoint an experienced and committed Clinical Trial Programme Manager to work within the Drug Development Unit (DDU) at the ICR and RM. The Unit delivers industry/academic -sponsored early phase clinical trials of new anticancer drugs. The DDU is one of the leading clinical trial units in the world that undertakes early-phase oncology trials for solid tumours. Over the years, DDU has played a significant role in transitioning several anti-cancer drugs from bench -to-bedside, many of which have now become standard of care cancer treatments. The Unit has a dedicated ward within the Royal Marsden Hospital for the development of novel cancer therapeutics, which we believe will improve the care of cancer patients.
Key Requirements
The post holder will be educated to at least degree level in life sciences or a health related area, with previous experience of managing and working in clinical trials with an excellent understanding of the conduct of Phase I oncology trials. They must be able to manage a team of skilled people and several complex studies at a time.
The post holder will be key to the communication and operations with the unit’s management group, clinical study team and with external partners, ensuring that studies are run to protocol and in accordance with ICH-GCP.
The post holder must be highly organised and able to plan work around a busy clinical unit. They should have excellent communication and interpersonal skills in order to interact effectively with unit staff and patients.
Institution Information The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment. The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.
The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our research rapidly into the clinic, with the aim of developing better treatments for cancer patients.
Department/Directorate Information
The ICR and The Royal Marsden are internationally renowned for our work together to conduct early- and late-phase clinical trials. Our joint Drug Development Unit, which sees around 300 patients per year, is one of the largest centres for phase I trials in the world and makes an important contribution to the worldwide effort to discover and develop new cancer drugs.
The Drug Development Unit, is led by Professor Johann de Bono, comprises of clinicians, scientists, data and study management staff, and focuses on providing a seamless conduit between pre-clinical drug discovery, proof of principle Phase-1 clinical trials and tumour specific evaluation of novel agents. The Unit undertakes both industry-sponsored and investigator-initiated trials of new anti-cancer drugs. The Unit is rapidly expanding and provides an excellent opportunity for the post holder to develop a variety of skillsets.
This post also benefits from generous annual leave entitlement and a pension.
To apply for this post, please submit an online application including a supporting statement, detailing reasons why you are applying for the post and with your CV.